Declines in vaccine-type human papillomavirus prevalence in females across racial/ethnic groups: data from a national survey
NM McClung, RM Lewis, JW Gargano, T Querec… - Journal of Adolescent …, 2019 - Elsevier
Purpose To monitor human papillomavirus (HPV) vaccine impact in the US, we evaluated
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …
quadrivalent vaccine (4vHPV)-type prevalence among females aged 14–34 years in the …
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14–26 year old females in the US
Background Low human papillomavirus (HPV) vaccination rates early after introduction,
particularly among low income and minority adolescents, may have resulted in disparities in …
particularly among low income and minority adolescents, may have resulted in disparities in …
Incidence and types of human papillomavirus infections in adolescent girls and young women immunized with the human papillomavirus vaccine
NF Schlecht, A Diaz, A Nucci-Sack… - JAMA Network …, 2021 - jamanetwork.com
Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …
Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014
SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …
[HTML][HTML] What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?
Purpose To identify factors that explain differences in HPV vaccination rates for male and
female adolescents and to determine self-reported barriers by parents affecting vaccination …
female adolescents and to determine self-reported barriers by parents affecting vaccination …
Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a …
JA Kahn, LE Widdice, L Ding, B Huang… - Clinical Infectious …, 2016 - academic.oup.com
abstract Background. Human papillomavirus (HPV) vaccine effectiveness and herd
protection are not well established in community settings. Our objective was to determine …
protection are not well established in community settings. Our objective was to determine …
Prevalence of HPV after introduction of the vaccination program in the United States
LE Markowitz, G Liu, S Hariri, M Steinau, EF Dunne… - …, 2016 - publications.aap.org
BACKGROUND: Since mid-2006, human papillomavirus (HPV) vaccination has been
recommended for females aged 11 to 12 years and through 26 years if not previously …
recommended for females aged 11 to 12 years and through 26 years if not previously …
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition …
LE Markowitz, S Hariri, C Lin, EF Dunne… - The Journal of …, 2013 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination was introduced into the routine
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
Non–vaccine-type human papillomavirus prevalence after vaccine introduction: No evidence for type replacement but evidence for cross-protection
M Saccucci, EL Franco, L Ding… - Sexually transmitted …, 2018 - journals.lww.com
Background We examined non–vaccine-type human papillomavirus (HPV) prevalence in a
community before and during the first 8 years after vaccine introduction, to assess for (1) …
community before and during the first 8 years after vaccine introduction, to assess for (1) …
Human papillomavirus vaccination in the United States: Uneven uptake by gender, race/ethnicity, and sexual orientation
J Daniel-Ulloa, PA Gilbert… - American Journal of …, 2016 - ajph.aphapublications.org
Objectives. To assess national differences in human papillomavirus (HPV) vaccine uptake
among young adults in the United States by gender, race/ethnicity, and sexual orientation …
among young adults in the United States by gender, race/ethnicity, and sexual orientation …